Dramatic Response of Pulmonary Sarcomatoid Carcinoma to Nivolumab Combined with Anlotinib: A Case Report

Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of non-small-cell lung cancer, which is resistant to the conventional chemotherapy and radiotherapy with a poor prognosis. Limited case reports have showed good response to the immunotherapy in PSC patients with high PD-L1 expression generally....

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Caibao, Yang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315215/
https://www.ncbi.nlm.nih.gov/pubmed/32595469
http://dx.doi.org/10.1159/000507568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315215/
https://www.ncbi.nlm.nih.gov/pubmed/32595469
http://dx.doi.org/10.1159/000507568

Ejemplares similares